The effect of chromium on inflammatory markers, 1st and 2nd phase insulin secretion in type 2 diabetes

European Journal of Nutrition

Volumn 53, Issue 1, 2014, Pages 127-133

  Chen, Yen Lin ^a   Lin, Jiunn Diann ^b   Hsia, Te Lin ^a   Mao, Frank Chiahung ^c   Hsu, Chun Hsien ^a   Pei, Dee ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Chromium; Insulin secretion; Insulin sensitivity; Interleukin 6; Tumor necrosis factor

Indexed keywords

ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; CHROMIUM; CREATININE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; URIC ACID;

EID: 84895076830     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-013-0508-8     Document Type: Article

References (28)

1. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S (2011) Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med 154(8):554-559. doi: 10.1059/0003-4819-154-8-201104190-00007
2. Zafar A, Davies M, Azhar A, Khunti K (2010) Clinical inertia in management of T2DM. Prim Care Diabetes 4(4):203-207. doi: 10.1016/j.pcd.2010.07. 003
3. Zeyda M, Stulnig TM (2009) Obesity, inflammation, and insulin resistance - a mini-review. Gerontology 55(4):379-386. doi: 10.1159/000212758
4. Sjoholm A, Nystrom T (2005) Endothelial inflammation in insulin resistance. Lancet 365(9459):610-612. doi: 10.1016/S0140-6736(05)17912-4
5. Tuman RW, Doisy RJ (1977) Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice. Diabetes 26(9):820-826
6. Kim CW, Kim BT, Park KH, Kim KM, Lee DJ, Yang SW, Joo NS (2011) Effects of short-term chromium supplementation on insulin sensitivity and body composition in overweight children: randomized, double-blind, placebo-controlled study. J Nutr Biochem. doi: 10.1016/j.jnutbio.2010.10.001
7. Ghosh D, Bhattacharya B, Mukherjee B, Manna B, Sinha M, Chowdhury J, Chowdhury S (2002) Role of chromium supplementation in Indians with type 2 diabetes mellitus. J Nutr Biochem 13(11):690-697
8. Riales R, Albrink MJ (1981) Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr 34(12):2670-2678
9. Pei D, Hsieh CH, Hung YJ, Li JC, Lee CH, Kuo SW (2006) The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metabolism 55(7):923-927. doi: 10.1016/j.metabol.2006.02.021
10. Catelas I, Petit A, Zukor DJ, Antoniou J, Huk OL (2003) TNF-alpha secretion and macrophage mortality induced by cobalt and chromium ions in vitro-qualitative analysis of apoptosis. Biomaterials 24(3):383-391
11. Shimizu H, Ohtani K, Kato Y, Mori M (2000) Interleukin-6 increases insulin secretion and preproinsulin mRNA expression via Ca2 + -dependent mechanism. J Endocrinol 166(1):121-126
12. Jain SK, Kahlon G, Morehead L, Dhawan R, Lieblong B, Stapleton T, Caldito G, Hoeldtke R, Levine SN, Bass PF 3rd (2012) Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-alpha, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study. Mol Nutr Food Res 56(8):1333-1341. doi: 10.1002/mnfr.201100719
13. Suzuki T, Imai J, Yamada T, Ishigaki Y, Kaneko K, Uno K, Hasegawa Y, Ishihara H, Oka Y, Katagiri H (2011) Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: potential involvement of the PLC-IP3-dependent pathway. Diabetes 60(2):537-547. doi: 10.2337/db10-0796
14. Jain SK, Lim G (2006) Chromium chloride inhibits TNF alpha and IL-6 secretion in isolated human blood mononuclear cells exposed to high glucose. Horm Metab Res 38(1):60-62. doi: 10.1055/s-2006-924981
15. Chen WY, Chen CJ, Liu CH, Mao FC (2009) Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes Metab 11(4):293-303. doi: 10.1111/j.1463-1326.2008.00936.x
16. Hansen T, Drivsholm T, Urhammer SA, Palacios RT, Volund A, Borch-Johnsen K, Pedersen O (2007) The BIGTT test: a novel test for simultaneous measurement of pancreatic beta-cell function, insulin sensitivity, and glucose tolerance. Diabetes Care 30(2):257-262. doi: 10.2337/dc06-1240
17. Dalla Man C, Campioni M, Polonsky KS, Basu R, Rizza RA, Toffolo G, Cobelli C (2005) Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. Diabetes 54(11):3265-3273
18. Kim TH CS, Ha ES, Jung JG, Han SJ, Kim HJ, Kim DJ, Kang Y, Lee KW. (2011) IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle. Acta Diabetol. doi: 10.1007/s00592-011- 0259-z
19. Yang WU, Zhi-he HU, Jia GUO (2010) Hypoglycemic effect of lactoferrin-chromium complex in experimental diabetic mice. Food Sci 31(13):253-258
20. Jain SK, Croad JL, Velusamy T, Rains JL, Bull R (2010) Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Mol Nutr Food Res 54(9):1371-1380. doi: 10.1002/mnfr.200900177
21. Jain SK, Rains JL, Croad JL (2007) Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 43(8):1124-1131
22. Plomgaard PNA, Fischer CP, Mortensen OH, Broholm C, Penkowa M, Krogh-Madsen R, Erikstrup C, Lindegaard B, Petersen AM, Taudorf S, Pedersen BK (2007) Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia 50(12):2562-2571
23. Nieto-Vazquez IF-VS, Krämer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M (2008) Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem 114(3):183-194
24. Cerasi E, Luft R (1963) Plasma-insulin response to sustained hyperglycemia induced by glucose infusion in human subjects. Lancet 2(7322):1359-1361
25. Caumo A, Luzi L (2004) First-phase insulin secretion: does it exist in real life? Considerations on shape and function. Am J Physiol Endocrinol Metab 287(3):E371-E385
26. Del Prato S, Tiengo A (2001) The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab Res Rev 17(3):164-174
27. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, Bonadonna R (2005) Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 54(6):1735-1743
28. LE Andreozzi F, Cardellini M, Marini MA, Lauro R, Hribal ML, Perticone F, Sesti G (2006) Plasma interleukin-6 levels are independently associated with insulin secretion in a cohort of Italian-Caucasian nondiabetic subjects. Diabetes 55(7):2021-2024